Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$9.83 - $9.96 $850,295 - $861,540
-86,500 Reduced 41.27%
123,100 $1.22 Million
Q4 2022

Feb 13, 2023

BUY
$5.91 - $10.14 $675,513 - $1.16 Million
114,300 Added 119.94%
209,600 $2.09 Million
Q3 2022

Nov 14, 2022

SELL
$3.65 - $6.74 $71,175 - $131,430
-19,500 Reduced 16.99%
95,300 $525,000
Q2 2022

Aug 12, 2022

SELL
$3.65 - $6.04 $79,935 - $132,276
-21,900 Reduced 16.02%
114,800 $419,000
Q1 2022

May 13, 2022

SELL
$5.01 - $8.77 $742,482 - $1.3 Million
-148,200 Reduced 52.02%
136,700 $827,000
Q4 2021

Feb 11, 2022

SELL
$7.64 - $10.11 $953,472 - $1.26 Million
-124,800 Reduced 30.46%
284,900 $2.4 Million
Q3 2021

Nov 12, 2021

SELL
$7.35 - $9.93 $307,230 - $415,074
-41,800 Reduced 9.26%
409,700 $3.71 Million
Q2 2021

Aug 13, 2021

BUY
$5.37 - $8.95 $249,705 - $416,174
46,500 Added 11.48%
451,500 $3.66 Million
Q1 2021

May 13, 2021

BUY
$3.54 - $6.46 $641,448 - $1.17 Million
181,200 Added 80.97%
405,000 $2.23 Million
Q4 2020

Feb 10, 2021

BUY
$1.66 - $4.81 $202,354 - $586,339
121,900 Added 119.63%
223,800 $761,000
Q3 2020

Nov 13, 2020

BUY
$1.27 - $1.88 $10,922 - $16,167
8,600 Added 9.22%
101,900 $172,000
Q2 2020

Aug 13, 2020

BUY
$1.64 - $2.5 $6,396 - $9,750
3,900 Added 4.36%
93,300 $153,000
Q1 2020

May 14, 2020

BUY
$1.27 - $3.19 $4,445 - $11,165
3,500 Added 4.07%
89,400 $172,000
Q4 2019

Feb 13, 2020

BUY
$2.65 - $3.4 $10,070 - $12,920
3,800 Added 4.63%
85,900 $245,000
Q3 2019

Nov 13, 2019

BUY
$2.52 - $3.79 $18,648 - $28,046
7,400 Added 9.91%
82,100 $270,000
Q2 2019

Aug 12, 2019

BUY
$3.25 - $3.96 $11,700 - $14,256
3,600 Added 5.06%
74,700 $243,000
Q1 2019

May 14, 2019

SELL
$3.07 - $4.0 $9,517 - $12,400
-3,100 Reduced 4.18%
71,100 $266,000
Q4 2018

Feb 13, 2019

BUY
$3.19 - $7.23 $236,698 - $536,466
74,200 New
74,200 $256,000

Others Institutions Holding APEN

# of Institutions
1
Shares Held
527K
Call Options Held
0
Put Options Held
0

About Apollo Endosurgery, Inc.


  • Ticker APEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,686,500
  • Description
  • Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible en...
More about APEN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.